News in Brief: Study Identifies Safest Duration of Oral Steroid Use for AD Flares
Limiting the use of oral corticosteroid treatment to 90 days or less may limit adverse effects in patients with atopic dermatitis (AD). This is the main takeaway from a new nested case-control study in JAMA Network Open that looked at the long-term use of oral corticosteroids and safety outcomes for AD patients. Specifically, the use […]